$364.60 2.1%
SYK Stock Price vs. AI Score
Data gathered: December 22

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Stryker (SYK)

Analysis generated August 27, 2024. Powered by Chat GPT.

Stryker Corporation is one of the world’s leading medical technology companies. With headquarters in Kalamazoo, Michigan, the company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes. Driven by a philosophy that emphasizes innovation and excellence, Stryker has grown consistently over the years, strengthening its market position and creating value for its stakeholders.

Read full AI stock Analysis

Stock Alerts - Stryker (SYK)

company logo Stryker | December 16
Job postings are down by 26.8% in the last couple of days.
company logo Stryker | December 3
Job postings are down by 30% in the last couple of days.
company logo Stryker | November 26
Job postings are down by 19.6% in the last couple of days.
company logo Stryker | November 19
Insider Alert: Stiles Spencer S is selling shares

About Stryker

Stryker Corporation operates as a medical technology company. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.


Stryker
Price $364.60
Target Price Sign up
Volume 3,100,000
Market Cap $139B
Year Range $315.24 - $392.15
Dividend Yield 0.94%
PE Ratio 38.3
Analyst Rating 82% buy
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '245.49B1.98B3.52B834M1.24B2.870
Q2 '245.42B2.01B3.42B825M1.21B2.810
Q1 '245.24B1.91B3.33B788M1.13B2.500
Q4 '235.82B2.11B3.7B1.14B1.41B3.460
Q3 '234.91B1.75B3.16B692M1.1B2.460

Insider Transactions View All

Stiles Spencer S filed to sell 50,611 shares at $391.2.
November 18 '24
Fink M Kathryn filed to sell 11,994 shares at $370.6.
September 17 '24
Fink M Kathryn filed to sell 17,131 shares at $361.2.
September 17 '24
Fink M Kathryn filed to sell 10,042 shares at $372.6.
September 17 '24
Fink M Kathryn filed to sell 12,808 shares at $368.
September 17 '24

What is the Market Cap of Stryker?

The Market Cap of Stryker is $139B.

What is Stryker's PE Ratio?

As of today, Stryker's PE (Price to Earnings) ratio is 38.3.

What is the current stock price of Stryker?

Currently, the price of one share of Stryker stock is $364.60.

How can I analyze the SYK stock price chart for investment decisions?

The SYK stock price chart above provides a comprehensive visual representation of Stryker's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Stryker shares. Our platform offers an up-to-date SYK stock price chart, along with technical data analysis and alternative data insights.

Does SYK offer dividends to its shareholders?

Yes, Stryker (SYK) offers dividends to its shareholders, with a dividend yield of 0.94%. This dividend yield represents Stryker's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Stryker in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Stryker?

Some of the similar stocks of Stryker are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Becton Dickinson and Co.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.